Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Eribulin mesylate (Halaven) has been approved to treat unresectable or metastasized liposarcoma. It is the first drug found to increase survival time in patients with the disease.